Metraipolis › archive › dc_bbb311a996b3

[68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report — Europe PMC PMID:41922613

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41922613
DOI
10.1186/s13550-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-03T12:15:52.241Z
SHA-256 of the archived text
b68b9700dca5d7bb2636081a81bce413e4bf474bfe3d9fc1986b689418155ac0
Stable URL of this page
https://metraipolis.com/documento/dc_bbb311a996b3

How to cite

[68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report — Europe PMC PMID:41922613 — Europe PMC (en), https://europepmc.org/article/MED/41922613 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbb311a996b3 (Metraipolis archive dc_bbb311a996b3, sha256 b68b9700dca5d7bb2636081a81bce413e4bf474bfe3d9fc1986b689418155ac0)
BibTeX
@misc{dcbbb311a996b3,
  title = {[68Ga]Ga-HER2 Affibody PET/CT for early prediction of neoadjuvant therapy outcome in HER2-positive breast cancer: a preliminary report — Europe PMC PMID:41922613},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41922613},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbb311a996b3; sha256 b68b9700dca5d7bb2636081a81bce413e4bf474bfe3d9fc1986b689418155ac0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41922613. Agents can read the archived copy with the MCP tool read_document.